APOA1 and cardiovascular disorder: Rpl17, a ribosomal protein, has been reported to function as an inhibitor of vascular smooth muscle growth and regulate vascular function via an extraribosomal function in cardiovascular diseases.[53] Apoa1 is a principal protein moiety in high‐density lipoprotein, which is atheroprotective.